CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 29, 2014	Mar. 30, 2013
Cash flows from operating activities:
Consolidated net income	$ 107,192	$ 77,958
Adjustments to reconcile consolidated net income to net cash provided by (used for) operations:
Depreciation and amortization	36,571	31,505
Amortization of stock-based compensation	9,796	5,983
Equity in earnings of affiliated companies	(1,417)	(1,983)
Deferred income taxes	10,641	19,584
Restructuring, integration, and other charges	8,020	15,495
Excess tax benefits from stock-based compensation arrangements	(5,862)	(6,475)
Other	1,492	1,596
Change in assets and liabilities, net of effects of acquired businesses:
Accounts receivable	904,719	388,980
Inventories	72,001	(25,377)
Accounts payable	(859,288)	(467,797)
Accrued expenses	(127,226)	(173,437)
Other assets and liabilities	(32,602)	(45,436)
Net cash provided by (used for) operating activities	124,037	(179,404)
Cash flows from investing activities:
Cash consideration paid for acquired businesses	(60,224)	(9,382)
Acquisition of property, plant, and equipment	(32,843)	(26,751)
Other	0	(3,000)
Net cash used for investing activities	(93,067)	(39,133)
Cash flows from financing activities:
Change in short-term and other borrowings	(7,338)	(14,342)
Proceeds from (repayment of) long-term bank borrowings, net	(85,000)	44,300
Net proceeds from note offering	0	591,156
Redemption of senior notes	0	(338,184)
Proceeds from exercise of stock options	16,142	10,600
Excess tax benefits from stock-based compensation arrangements	5,862	6,475
Repurchases of common stock	(88,501)	(113,504)
Net cash provided by (used for) financing activities	(158,835)	186,501
Effect of exchange rate changes on cash	(4,454)	(13,497)
Net decrease in cash and cash equivalents	(132,319)	(45,533)
Cash and cash equivalents at beginning of period	390,602	409,684
Cash and cash equivalents at end of period	$ 258,283	$ 364,151